Conclusion:
Hypercoagulability and severe inflammatory stress leading to
life-threatening illness is a significant complication of COVID-19
infection. There should be a low threshold of suspecting and treating
hypercoagulability and inflammation-induced myocardial ischemia and
injury with cardiogenic shock. Early recognition and management would be
an appropriate strategy to decrease acute as well as chronic morbidity
and mortality.
Acknowledgment : None Declared by authors
Source of funding: None